| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/25/2006 | US7034154 Reacting a pyrazole with an enaminone to yield a halopyrazol-opyrimidine which is reacted with 2-thiophenecarboxylic acid chloride in the presence of zinc or magnesium or 2-thiophene boronic acid in the presence of carbon monoxide |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034038 Gastrointestinal disorders; antiulcer agents caused by Helicobacter |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/25/2006 | US7034030 Pyralopyridines, process for their preparation and use as therapeutic compounds |
| 04/25/2006 | US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/25/2006 | US7033575 Delivery of physiologically active compounds through an inhalation route |
| 04/25/2006 | US7033541 Bicarbonate receptor compounds |
| 04/20/2006 | WO2006042289A2 Substituted biaryl quinolin-4-ylamine analogues |
| 04/20/2006 | WO2006041900A2 SUBSTITUTED N-ARYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS |
| 04/20/2006 | WO2006040966A1 Aromatic-ring-fused pyrimidine derivative |
| 04/20/2006 | WO2006040451A2 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
| 04/20/2006 | WO2006040329A1 1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 04/20/2006 | WO2006040056A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 04/20/2006 | WO2006040052A1 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity |
| 04/20/2006 | WO2006040049A1 Novel azaindole thiazolinones as anti-cancer agents |
| 04/20/2006 | WO2006040039A1 N,n'-dithenylurea derivatives used in the form of kinase inhibitors |
| 04/20/2006 | WO2006009755A3 Azaindoles modulating c-kit activity and uses therefor |
| 04/20/2006 | WO2005115398A3 Hiv integrase inhibitors |
| 04/20/2006 | WO2005113513A3 Aryl sulfonamides |
| 04/20/2006 | WO2005040155A8 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | WO2005023255A3 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 04/20/2006 | WO2005016913A8 Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
| 04/20/2006 | US20060084806 Processes for the preparation of imidazo[1,2-a] pyridine derivatives |
| 04/20/2006 | US20060084803 Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 04/20/2006 | US20060084674 Azaindole thiazolinones |
| 04/20/2006 | US20060084673 1,5-naphthyridine azolinone |
| 04/20/2006 | US20060084664 Substituted pyrido(1,2-A) pyrimidines and their use as NOS inhibitors |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084651 Chemical compounds |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | CA2584185A1 Heterocyclic substituted bisarylurea derivates as kinase inhibitors |
| 04/20/2006 | CA2584179A1 N,n'-diphenylurea derivatives which are suitable as kinase inhibitors |
| 04/20/2006 | CA2583192A1 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity |
| 04/20/2006 | CA2582986A1 Novel azaindole thiazolinones as anti-cancer agents |
| 04/20/2006 | CA2580419A1 Novel insecticides |
| 04/19/2006 | EP1646659A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/19/2006 | EP1646632A2 Substituted tetrahydro-1 i h /i -pyrazolo 3,4-c|pyridines, compositions containing same and use |
| 04/19/2006 | EP1646631A1 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors; and intermediates thereof |
| 04/19/2006 | EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 04/19/2006 | EP1646611A1 Hydroxypyridine cgrp receptor antagonists |
| 04/19/2006 | EP1646388A2 Cytotoxic indeno and isoindoloisoquinolones |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |
| 04/19/2006 | EP1353921B1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP1196167B1 Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761651A 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252069C 2-aryl-naphthyridin-4-ones as antitumor agent |
| 04/19/2006 | CN1252054C Qinoline derivatives inhibiting effect of growth factors |
| 04/18/2006 | US7030271 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof |
| 04/18/2006 | US7030139 Compounds |
| 04/18/2006 | US7030138 Benzamidine derivatives |
| 04/18/2006 | US7030136 Administering phanquinone to the subject, optionally together with one or more pharmaceutically acceptable carriers for improving the learning or memory of a normal subject |
| 04/18/2006 | US7030134 such as N-cyclopentyl-2-(4-fluorophenyl)-3-[2-(1-pyrrolidinyl)-4-pyrimidinyl]-6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-7-amine; for treatment of herpes viral infections |
| 04/18/2006 | US7030131 such as N-[4-(4-amino-1H-imidazol[4,5-c]quinolin-1-yl)butyl]-5-(dimethylamino)-naphthalenesulfonamide; for induction of biosynthesis of cytokines; immunomodulators; antineoplastic agents |
| 04/18/2006 | US7030125 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 04/18/2006 | US7030121 Pyrazolopyrazine compound and pharmaceutical use thereof |
| 04/18/2006 | US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same |
| 04/18/2006 | US7030108 Administering to patient effective amount of neurotransmission modulating composition comprising 5HT antagonist and/or alpha 2 antagonist |
| 04/18/2006 | US7029658 Delivery of antidepressants through an inhalation route |
| 04/18/2006 | CA2241852C Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 04/13/2006 | WO2006038923A2 Aryl substituted imidazonaphthyridines |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038587A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 04/13/2006 | WO2006038116A2 Triazolopyridine derivatives as antibacterial agents |
| 04/13/2006 | WO2006038041A1 Besylate salts of six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 04/13/2006 | WO2006037894A1 Method for enantioselective preparation of sulphoxide derivatives |
| 04/13/2006 | WO2006037748A1 Substituted tricyclic benzimidazoles |
| 04/13/2006 | WO2006037539A1 Halogenation of rylen-carboximides with elementary halogen in a two-phase mixture comprising an organic solvent and water, wherein formed halogen hydrocide is continuously removable from the organic solvent |
| 04/13/2006 | WO2006021401A3 Bicylononene derivatives |
| 04/13/2006 | WO2006008302A3 Improved process for the manufacture of mirtazapine |
| 04/13/2006 | WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals |
| 04/13/2006 | WO2005110416A3 4,5-disubstituted-2-aryl pyrimidines |
| 04/13/2006 | WO2005049559A3 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
| 04/13/2006 | US20060079546 Aminopiperidine derivatives as antibacterials |
| 04/13/2006 | US20060079531 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
| 04/13/2006 | US20060079529 6-7-8-9-Tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime derivatives such as 5-phenyl-6-7-8-9-tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime; sodium channel modulators; antiischemic agents |
| 04/13/2006 | US20060079528 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 04/13/2006 | US20060079499 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 04/13/2006 | US20060079497 Lavendamycin analogues and methods of synthesizing and using lavendamycin analogues |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2582482A1 Triazolopyridine derivatives as antibacterial agents |
| 04/13/2006 | CA2582294A1 Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders |
| 04/13/2006 | CA2582256A1 Substituted tricyclic benzimidazoles |
| 04/13/2006 | CA2580446A1 Method for enantioselective preparation of sulphoxide derivatives |
| 04/12/2006 | EP1645552A1 Double-spiro organic compounds and electroluminescent devices |
| 04/12/2006 | EP1644375A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2006 | EP1644373A1 Tricyclic delta opioid modulators |
| 04/12/2006 | EP1644372A2 Substituted quinolin-4-ylamine analogues |